WHO's second-edition dementia guideline says hearing aids may be offered to adults with hearing loss to reduce cognitive decline or dementia risk. Adults in midlife can track everyday listening problems and seek professional testing instead of diagnosing themselves. Hearing aids are small worn devices that make sounds louder to treat hearing loss. A conditional recommendation means WHO suggests the option when it fits the person, after weighing benefits and harms.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the official guidance from NIH — Use this primary source to verify the official guidance.
- Read the official guidance from Who — Use this primary source to verify the official guidance.
Table of Contents
- What changed in the 2026 guideline
- Who the advice covers
- What one large trial found
- What to track without self-diagnosing
What changed in the 2026 guideline
WHO published the second-edition guideline on 15 July 2026. It makes a conditional recommendation that hearing aids may be offered to adults with hearing loss, as stated in the guideline publication from WHO. The 2019 guidelines made no hearing-aid recommendation for dementia prevention because evidence was then judged insufficient.
WHO now stresses that hearing aids are primarily to treat hearing loss, not solely to prevent dementia. WHO concluded potential benefits probably outweigh harms given the burden of unaddressed loss. The shift reflects more follow-up data on hearing and cognition, not proof that aids alone stop dementia.
Who the advice covers
The advice targets adults without dementia. That includes people with normal cognition or mild impairment. It takes a life-course view rather than focusing only on older adults already diagnosed.
WHO announced that up to 45% of dementia risk could be prevented or delayed by addressing modifiable risks, with hearing loss among the leading factors, in the WHO announcement. The 2024 Lancet Commission linked about 45% of cases to 14 modifiable factors across life, according to BrightFocus Foundation reporting. Midlife matters because hearing loss, high LDL cholesterol, less education, and social isolation can accumulate risk over years. Action in midlife supports hearing now and brain health later.
What one large trial found
The ACHIEVE trial followed 977 adults ages 70 to 84 with untreated hearing loss for three years. One group received hearing intervention and support. The other group received health education.
Decline slowed by 48% in the higher-risk subgroup that received hearing intervention, according to Cochlear reporting of Lancet and AAIC 2023 results. The full study group showed no significant overall difference. That pattern limits causal claims. Benefit looked clearer for higher-risk participants than for all participants.
What to track without self-diagnosing
NIDCD lists everyday signs adults can notice in themselves or a partner. Note repeat requests, trouble on the phone or in noise, complaints that the TV is too loud, and withdrawal from social settings.
NIDCD advises a professional hearing test if two or more apply, as explained in the NIDCD hearing-test checklist. Useful tracking steps for midlife adults: WHO offers the free hearWHO app for periodic checks, with referral for formal testing after a failed check. WHO points to repeat checks especially after age 60 or with noisy or ototoxic exposures.
- Note when problems happen, such as calls, meetings, restaurants, or TV time.
- Ask family if they notice repeats, loud volume, or missed words.
- Record exposure to loud noise and drugs that can harm hearing.
- Book formal audiometric testing if the pattern persists or two signs apply.
You Might Also Like
- Air Pollution in the 2026 WHO Dementia Guideline: What Adults in Midlife Can Track Without Self-Diagnosing
- The WHO 45% Modifiable Dementia Risk Estimate in 2026: What Adults in Midlife Can Track Without Self-Diagnosing
- WHO’s Second Dementia Risk-Reduction Guideline in 2026: What Adults in Midlife Can Track Without Self-Diagnosing
